Neurofold Therapeutics
Greenwood Village, US · Founded 2024 · Delaware corporation · 1 known investors
Founders & leadership
RK
Rajeev KumarNamed on SEC filing
Board
GB
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.5M disclosed across 1 round · 2026
▶$6.5MraisedJul 2026 · 18 investors · BiotechnologyRule 506(b)
▶$6.5MraisedJul 2026 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rajeev KumarExecutive Officer, Director
- Gurdane BhutaniDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Minimum investment
- $10K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Neurofold Therapeutics's investors?
- Neurofold Therapeutics's investors include MBX Capital.
- How much funding has Neurofold Therapeutics raised?
- Neurofold Therapeutics has disclosed $6.5M raised across 1 round.
- Where is Neurofold Therapeutics headquartered?
- Neurofold Therapeutics is headquartered in Greenwood Village, US.